Amble vs Navio MD
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Amble
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Navio MD
Best for compounded tirzepatide with brand-name fallback across 48 statesStarting at $247/mo
Side-by-Side Comparison
| Feature | Amble | Navio MD |
|---|---|---|
| Overall Score | 7.4/10 | 7.4/10 |
| Starting Price | ✓$179/mo | $247/mo |
| Editorial Rating | 3.7 ★ /5 | 3.7 ★ /5 |
| Features | 3 features | ✓5 features |
| States Available | ✓50 | 48 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Amble
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Navio MD
Pros
- ✓LegitScript verified with board-certified providers and US-licensed pharmacies
- ✓Same price at every dose — no price escalation
- ✓Both compounded and brand-name options
- ✓48-state coverage
- ✓Hours 9am–10pm EST Mon–Sun
Cons
- ✗Not available in Alabama and Mississippi
- ✗Compounded option is tirzepatide only — no compounded semaglutide listed
- ✗Brand-name at near-retail pricing ($1,199–$1,249/mo)
- ✗Also offers women's HRT (broader platform)
Our Verdict
Both Amble and Navio MD score equally well overall — the right choice depends on your priorities. Choose Amble if you want mainstream telehealth GLP-1 access, or Navio MD if compounded tirzepatide with brand-name fallback across 48 states matters most to you.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.